PRECLINICAL PROFILE OF THE PAN-GENOTYPIC HCV NS3/4A PROTEASE INHIBITOR GS-9857

被引：23

作者：

Taylor, J. G. ^{[1
]}

Appleby, T. ^{[1
]}

Barauskas, O. ^{[1
]}

Chen, X. ^{[1
]}

Dvory-Sobol, H. ^{[1
]}

Gong, R. ^{[1
]}

Lee, J. ^{[1
]}

Nejati, E. ^{[1
]}

Schultz, B. ^{[1
]}

Wang, Y. ^{[1
]}

Yang, C. ^{[1
]}

Yu, M. ^{[1
]}

Zipfel, S. ^{[1
]}

Chan, K. ^{[1
]}

机构：

[1] Gilead Sci Inc, Foster City, CA 94404 USA

来源：

JOURNAL OF HEPATOLOGY | 2015年 / 62卷

关键词：

D O I：

10.1016/S0168-8278(15)31102-8

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P0899

引用

页码：S681 / S681

页数：1

共 50 条

[31] Discovery of GS-9451: An acid inhibitor of the hepatitis C virus NS3/4A protease
Sheng, X. Christopher
Appleby, Todd
Butler, Thomas
Cai, Ruby
Chen, Xiaowu
Cho, Aesop
Clarke, Michael O.
Cottell, Jeromy
Delaney, William E.
Doerffler, Edward
Link, John
Ji, Mingzhe
Pakdaman, Rowchanak
Pyun, Hyung-Jung
Wu, Qiaoyin
Xu, Jie
Kim, Choung U.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (07) : 2629 - 2634
[32] Discovery of GS-9256: A novel phosphinate HCV NS3 protease inhibitor
Sheng, Christopher
Clarke, Mike
Ji, Mingzhe
Pyun, Hyungjung
Wu, Qiaoyin
Cai, Ruby
Chaudhary, Kleem
Wang, Jianying
Tay, Chin
Chen, Xiaowu
Appleby, Todd
Pakdaman, Roshy
Yang, Chris
Yang, Huiling
Robinson, Margaret
Wang, Ruth
Doerffler, Edward
Liu, Xiaohong
Barauskas, Ona
Schultz, Brian
Delaney, Bill
Kim, Choung
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
[33] Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A
DeGoey, David A.
Randolph, John T.
Liu, Dachun
Pratt, John
Hutchins, Charles
Donner, Pamela
Krueger, A. Chris
Matulenko, Mark
Patel, Sachin
Motter, Christopher E.
Nelson, Lissa
Keddy, Ryan
Tufano, Michael
Caspi, Daniel D.
Krishnan, Preethi
Mistry, Neeta
Koev, Gennadiy
Reisch, Thomas J.
Mondal, Rubina
Pilot-Matias, Tami
Gao, Yi
Beno, David W. A.
Maring, Clarence J.
Molla, Akhter
Dumas, Emily
Campbell, Andrew
Williams, Laura
Collins, Christine
Wagner, Rolf
Kati, Warren M.
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (05) : 2047 - 2057
[34] Furaprevir HCV NS3/4A protease inhibitor Treatment of chronic hepatitis C virus infection
Ghosh, Prithwish
Nehra, Vandana
Temesgen, Zelalem
DRUGS OF THE FUTURE, 2022, 47 (08) : 557 - 565
[35] IN VITRO CHARACTERIZATION OF THE PAN-GENOTYPE ACTIVITY OF THE HCV NS3/4A PROTEASE INHIBITORS BOCEPREVIR AND TELAPREVIR
Howe, J. A.
Graham, D.
McMonagle, P.
Curry, S.
Chase, R.
Lahser, F.
Ogert, R. A.
Strizki, J.
Barnard, R. J. B. O.
Zhang, R.
Zhuyan, G.
Treitel, M.
Hazuda, D. J.
Howe, A. Y.
JOURNAL OF HEPATOLOGY, 2012, 56 : S329 - S329
[36] CHARACTERIZATION OF RESISTANT MUTANTS SELECTED IN VITRO BY THE HCV NS3/4A PROTEASE INHIBITOR BI 201335
Kukolj, G.
Bousquet, C.
Dansereau, N.
Do, F.
Lagace, L.
Llinas-Brunet, M.
Marquis, M.
Massariol, M. -J.
Maurice, R.
Spickler, C.
Thibeault, D.
Zhao, S.
White, P. W.
JOURNAL OF HEPATOLOGY, 2010, 52 : S295 - S295
[37] Process development of ABT-450-A first generation NS3/4A protease inhibitor for HCV
Caspi, Daniel D.
Cink, Russell D.
Clyne, Dean
Diwan, Moiz
Engstrom, Kenneth M.
Grieme, Timothy
Mei, Jianzhang
Miller, Robert W.
Mitchell, Clifford
Napolitano, Jose G.
Nere, Nandkishor
Ravn, Matthew M.
Sheikh, Ahmad
Wagaw, Seble
Zhang, Hongqiang
TETRAHEDRON, 2019, 75 (32) : 4271 - 4286
[38] Drug–Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir
Sivi Ouwerkerk-Mahadevan
Jan Snoeys
Monika Peeters
Maria Beumont-Mauviel
Alexandru Simion
Clinical Pharmacokinetics, 2016, 55 : 197 - 208
[39] Induction of human telomerase by HCV NS3/4A protease-helicase
Zhu, Zhaowen
Mathahs, M. Meleah
Schmidt, Warren N.
HEPATOLOGY, 2013, 58 : 1171A - 1171A
[40] Novel HCV NS3/4A protease inhibitors with tetrazoyl P* groups
Wang, Guoqiang
Sun, Ying
Jiang, Lijuan
Lu, Xiang
The-Uyen Phan
Chen, Zhigang
McDaniel, Keith K.
Kempf, Dale J.
Or, Yat Sun
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243

← 1 2 3 4 5 →